Supportive Care: 133 Real Stories
133 stories match supportive care. 80 of them mention surgery.
Final lung cancer blog entry: respiratory failure, palliative sedation, and family tribute
This final Noxte blog entry was written by the patient’s family, honoring the wish of their father and husband to keep readers informed. He had been diagnosed with lung cancer in February 2014 and had used the blog to share the medical course, the emotional…
Read this storyAdvanced metastatic lung cancer with bone metastases, pneumonia, and worsening pain
About 3 years after learning he had lung cancer, this Spanish blogger wrote a farewell post from a much harder point in the illness. Recent months had brought bone metastases, pneumonia, severe pain, feverish evenings, night sweats, low-oxygen episodes, and…
Read this storyStage II Breast Cancer: Natalia’s Survivor Story
Natalia, from Colombia, had a hard, growing lump in her left breast. An early ultrasound found nothing, and three months passed before a mastologist removed the lump and confirmed cancer. Dissatisfied with the information and manner of her first doctor, she…
Read this storyLung cancer follow-up complicated by pneumonia after pneumococcal vaccination
This Noxte entry focused less on a cancer treatment change and more on how fragile life with lung cancer had become. The patient had recently seen oncology on Friday, November 18. At that visit, his blood tests, lung exam, and oxygenation were reassuring, but…
Read this storyLung cancer follow-up with worsening fatigue, cough, chest pain, and CT wait
This Noxte post focused on the physical and emotional exhaustion of living from scan to scan with lung cancer. The patient had just had another CT and was scheduled to review results and blood work on 12 April. He was not optimistic because cough, chest pain…
Read this storyLung cancer on afatinib after liquid biopsy showed T790M resistance no longer detected
This Noxte post explained how liquid biopsy was beginning to affect the patient’s lung cancer care. He had been participating in blood-based monitoring to track treatment effects and possible resistance. At an oncology visit, his doctors had the latest blood…
Read this storyLung cancer with acquired T790M resistance: erlotinib switched to afatinib while AZD9291/TAGRISSO trial was considered
By January 2016, this Spanish lung cancer blogger was marking 2 years of survival while facing a new treatment setback. Recent bronchoscopy and blood testing confirmed that the cancer had developed resistance, including the T790M mutation. That finding…
Read this storyLung cancer progression on Tarceva with urgent T790M resistance testing planned
In January 2016, this lung cancer patient learned that a recent CT scan explained his worsening cough. The scan showed clear progression: the right upper-lobe mass had grown to about 4.9 x 5 cm, with extension to the visceral pleura, involvement around the…
Read this storyLung cancer follow-up: returning to golf while living with an ongoing tumor
By September 2015, this lung cancer patient was trying to rebuild ordinary life around ongoing disease. He wrote that the tumor was still in place, but he looked well, had no obvious outward symptoms, and was more than 1.5 years from diagnosis. Treatment side…
Read this storyLung cancer on erlotinib with side effects and CT results pending
In early March 2015, this lung cancer patient was in the difficult waiting period around a CT scan. He was taking erlotinib, also known as Tarceva, and the side effects were affecting both his body and his mood. People following his blog noticed that he was…
Read this storyLung cancer first-anniversary survival milestone with slower-than-expected tumor growth
In January 2015, this lung cancer patient marked 1 year since the disease was first detected. The previous year, a chest X-ray had shown a visible tumor, and a pulmonologist ordered the tests that confirmed lung cancer. The year that followed was hard, but…
Read this storyLung cancer on Erlotinib/Tarceva with rash, dyspepsia, mouth irritation, and fatigue
In January 2015, this lung cancer patient had just started Erlotinib, also called Tarceva. He began the oral treatment on January 2 and had been taking it fasting for more than 15 days. Early side effects were already noticeable. The most visible was a mild…
Read this storyStage III Breast Cancer: Mary’s Survivor Story
Mary was diagnosed with stage 3 metaplastic breast cancer in May 2007 after an 11-month delay. She had noticed a lump in her left breast, along with nipple discharge, redness, irritation, and thickening. Across nine medical visits, mammography, scanning…
Read this story